Insights

Strong Industry Position Ncardia is a recognized leader in stem cell-based drug discovery solutions, with recent product launches such as Ncyte NHP-C vCardiomyocytes and ready-to-use assay panels, indicating ongoing innovation and expanding product offerings that can address diverse client needs.

Global Reach & Collaborations Operating across Europe and North America, Ncardia collaborates with biopharmaceutical companies worldwide, presenting opportunities to tailor partnerships and expand sales channels in key biotech and pharma markets.

Recent Product Launches The launch of specialized products like ventricular-like cardiomyocytes derived from cynomolgus monkeys and comprehensive drug discovery platforms demonstrates Ncardia’s capability to meet advanced research demands, ideal for clients seeking cutting-edge solutions.

Financial & Funding Strength With over $60 million in strategic funding and a revenue range of $1 million to $10 million, Ncardia is well-capitalized to support growth initiatives and can be a compelling partner for joint ventures or contract research services.

Innovation & Infrastructure Ncardia’s investment in infrastructure like the Cellistic manufacturing platform and its expertise in iPSC technology position it as a go-to provider for companies seeking scalable, high-quality cell models, offering upsell opportunities in biomanufacturing and research services.

Similar companies to Ncardia

Ncardia Tech Stack

Ncardia uses 8 technology products and services including Matomo, Shopify, AMP, and more. Explore Ncardia's tech stack below.

  • Matomo
    Analytics
  • Shopify
    E-commerce
  • AMP
    Javascript Frameworks
  • OWL Carousel
    Javascript Libraries
  • Goober
    Javascript Libraries
  • Intercom
    Live Chat
  • UIKit
    UI Frameworks
  • Twitter
    Widgets

Media & News

Ncardia's Email Address Formats

Ncardia uses at least 1 format(s):
Ncardia Email FormatsExamplePercentage
First.Last@ncardia.comJohn.Doe@ncardia.com
88%
First.MiddleLast@ncardia.comJohn.MichaelDoe@ncardia.com
9%
FirLast@ncardia.comJohDoe@ncardia.com
2%
First@ncardia.comJohn@ncardia.com
1%

Frequently Asked Questions

Where is Ncardia's headquarters located?

Minus sign iconPlus sign icon
Ncardia's main headquarters is located at 8 Galileiweg Leiden, South Holland 2333 bd Netherlands. The company has employees across 2 continents, including EuropeNorth America.

What is Ncardia's official website and social media links?

Minus sign iconPlus sign icon
Ncardia's official website is ncardia.com and has social profiles on LinkedIn.

What is Ncardia's SIC code NAICS code?

Minus sign iconPlus sign icon
Ncardia's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Ncardia have currently?

Minus sign iconPlus sign icon
As of February 2026, Ncardia has approximately 45 employees across 2 continents, including EuropeNorth America. Key team members include CSO: H. B.Chief People Officer: V. D.Vice President Marketing: D. S.. Explore Ncardia's employee directory with LeadIQ.

What industry does Ncardia belong to?

Minus sign iconPlus sign icon
Ncardia operates in the Biotechnology Research industry.

What technology does Ncardia use?

Minus sign iconPlus sign icon
Ncardia's tech stack includes MatomoShopifyAMPOWL CarouselGooberIntercomUIKitTwitter.

What is Ncardia's email format?

Minus sign iconPlus sign icon
Ncardia's email format typically follows the pattern of First.Last@ncardia.com. Find more Ncardia email formats with LeadIQ.

How much funding has Ncardia raised to date?

Minus sign iconPlus sign icon
As of February 2026, Ncardia has raised $60M in funding. .

When was Ncardia founded?

Minus sign iconPlus sign icon
Ncardia was founded in 2011.

Ncardia

Biotechnology ResearchSouth Holland, Netherlands11-50 Employees

Ncardia is a drug discovery company and expert in human iPSC technology. We operate worldwide with facilities, offices and staff throughout Europe and North America. We work with biopharmaceutical companies in drug discovery worldwide, to leverage the power of stem cell technologies in the development of novel therapies of multiple modalities at any stage of development. 

Over the past 10 years, we have built the expertise and infrastructure required to differentiate, manufacture and characterize high-quality iPSC-derived cell and disease models. We can facilitate the process of disease modeling and high-throughput screening to accelerate drug discovery.
We listen to our customer’s project plans, questions and challenges, and co-develop human iPSC-based solutions that fit their specifications.

Explore our website to learn more www.ncardia.com.

Section iconCompany Overview

Headquarters
8 Galileiweg Leiden, South Holland 2333 bd Netherlands
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2011
Employees
11-50

Section iconFunding & Financials

  • $60M

    Ncardia has raised a total of $60M of funding over 1 rounds. .

  • $1M$10M

    Ncardia's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $60M

    Ncardia has raised a total of $60M of funding over 1 rounds. .

  • $1M$10M

    Ncardia's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.